–
Galmed Pharmaceuticals Ltd.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−32.9
FY22:
−17.7
FY23:
−7.49
FY24:
−6.28
FY25:
−8.51
(positive)
Change from FY21 to FY25
millions USD
FY21:
−32.7
FY22:
−17.1
FY23:
−7.68
FY24:
−5.08
FY25:
−5.89
(positive)
Change from FY21 to FY25
millions USD
FY21:
−32.5
FY22:
17.9
FY23:
6.91
FY24:
7.52
FY25:
−10.3
(positive)
Change from FY21 to FY25
millions USD
FY21:
−32.5
FY22:
−17.9
FY23:
−6.91
FY24:
−7.52
FY25:
−10.3
All amounts in millions USD